Procalcitonin testing may reduce antibiotic use in acute pancreatitis

Procalcitonin-guided care reduced antibiotic use without increasing the risk for infection among patients with acute pancreatitis compared with standard care, according to research published in The Lancet Gastroenterology and Hepatology.“None of these features [of acute pancreatitis] discriminate between inflammation and infection, resulting globally in overuse of antibiotics across the spectrum of disease severity, with up to two-thirds of patients with acute pancreatitis receiving at least one course of antibiotics during their admission. One method of distinguishing infection fromRead More

Categories: News

Related Articles

Outpatient antibiotic management safe for select adults with acute appendicitis

Outpatient antibiotic management was safe compared with in-hospital care, with no greater risk for complications or appendectomy, in a subgroup of patients with acute appendicitis,…

Antibiotic use linked with an increased risk for older-onset IBD

The use of antibiotics, particularly those targeting gastrointestinal pathogens, was associated with an increased risk for older-onset inflammatory bowel disease, according to a researcher at…

Relapse risk doubles in UC patients with histologic inflammation

SAN DIEGO — Among ulcerative colitis patients in endoscopic remission, histologic inflammation increased the risk for loss of remission, according to a presentation at Digestive…

Higher fiber intake reduces inflammation, CVD risk in older adults

Higher fiber intake, specifically cereal fiber, was associated with lower levels of inflammation and a reduced risk for CVD in older adults, according to findings…

No difference in HCC risk between tenofovir, entecavir for chronic HBV infection

There was no clinically meaningful difference in the risk for hepatocellular carcinoma between patients taking tenofovir vs. entecavir to treat chronic hepatitis B virus infection,…